Effect of japanese traditional medicine, TJ-14, on QOL for patients with non-small lung cancer receiving outpatient chemotherapy

Effect of japanese traditional medicine, TJ-14, on QOL for patients with non-small lung cancer receiving outpatient chemotherapy - Effect of TJ-14 on QOL for patients with non-small lung cancer receiving outpatient chemotherapy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016294

Enrollment

Registered

2015-02-01

Start date

2015-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small lung cancer

Interventions

To investigate the factors influencing the QOL for these patients, we answered using a QOL questionaire, &quot

The QOL Questionnaire for Cancer Patients Treated with Anticancer Drugs&quot

(QOL-ACD) to patients with non-small cell lung cancer.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with non-small lung cancer undergoing outpatient chemotherapy of PS 0-1

Exclusion criteria

Exclusion criteria: Poor status of PS, over 2.

Design outcomes

Primary

Measure	Time frame
the quality of life (QOL)	—

Countries

Japan

Contacts

Public ContactYoshihisa Ishiura

Toyama City Hospital Oncology Medicine

ishiura@tch.toyama.toyama.jp076-422-1112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026